CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-16 | Siegel Jolie Chief Legal Officer | Shares withheld for taxes | −661 | $6.36 | $4K | 53,840 |
| 2024-09-16 | Siegel Jolie Chief Legal Officer | Option exercise · Performance Restricted Stock Units | −2,250 | 14,250 | ||
| 2024-08-29 | Fawell Stephen Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2024-07-10 | REYNO LEONARD Chief Medical Officer | Shares withheld for taxes | −6,191 | $5.00 | $31K | 91,809 |
| 2024-07-01 | GROGAN DONNA ROY Director | Grant or award | +2,836 | $4.85 | $14K | 26,468 |
| 2024-07-01 | Anderson Kenneth Carl Director | Grant or award | +2,320 | $4.85 | $11K | 114,671 |
| 2024-06-20 | Hughes Owen Director | Grant or award · Stock Option (Right to Buy) | +32,500 | 32,500 | ||
| 2024-06-20 | Bessen Laura Director | Grant or award · Stock Option (Right to Buy) | +32,500 | 32,500 | ||
| 2024-06-20 | Koppikar Utpal Director | Grant or award · Stock Option (Right to Buy) | +32,500 | 32,500 | ||
| 2024-06-20 | DOWNEY BRUCE Director | Grant or award · Stock Option (Right to Buy) | +32,500 | 32,500 | ||
| 2024-06-20 | Salter Malcolm Director | Grant or award · Stock Option (Right to Buy) | +32,500 | 32,500 | ||
| 2024-06-20 | Anderson Kenneth Carl Director | Grant or award · Stock Option (Right to Buy) | +32,500 | 32,500 | ||
| 2024-06-20 | GROGAN DONNA ROY Director | Grant or award · Stock Option (Right to Buy) | +32,500 | 32,500 | ||
| 2024-06-07 | Cooper Ronald Harold Wilfred Director | Grant or award · Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2024-04-01 | Anderson Kenneth Carl Director | Grant or award | +1,389 | $8.10 | $11K | 112,351 |
| 2024-04-01 | Dubin Glenn Director | Grant or award | +1,358 | $8.10 | $11K | 22,075 |
| 2024-04-01 | GROGAN DONNA ROY Director | Grant or award | +1,697 | $8.10 | $14K | 23,632 |
| 2024-03-07 | Boyle Scott N Chief Business Officer | Returned to the company · Stock Option (Right to Buy) | −115,000 | 0 | ||
| 2024-03-07 | Boyle Scott N Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2024-03-07 | Fisher Stewart Chief Scientific Officer | Returned to the company · Stock Option (Right to Buy) | −94,950 | 0 |
Page 8 of 27 · 525 trades